Patent Assignment
Reel/Frame 049809/0931
Assignment of Assignor's Interest
Recorded: 2019-07-20
Pages: 8
Assignor
SPITFIRE PHARMA INC.
Executed: 2019-07-12
Assignee
MEDERIS DIABETES INC.
725 LYNWOOD DR., ENCINITAS, CALIFORNIA, 92024
Covered Properties
(3)
Improved Peptide Pharmaceuticals for Insulin Resistance
Peptide Pharmaceuticals for Insulin Resistance
Peptide Pharmaceuticals for Insulin Resistance
Application:
62/004,156 →
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 28, 2015
From: NESTOR, JOHN J.
To: MEDERIS DIABETES, LLC
Reel/Frame 035734/0133 →
Assignment of Assignor's Interest
Nov 20, 2017
From: NESTOR, JOHN J.
To: SPITFIRE PHARMA, INC.
Reel/Frame 044182/0962 →
Assignment of Assignor's Interest
Nov 20, 2017
From: NESTOR, JOHN J.
To: SPITFIRE PHARMA, INC.
Reel/Frame 044183/0041 →
Corrective Assignment to Correct the Assignee Name and Address Previously Recorded at Reel: 035734 Frame: 0133. Assignor(S) Hereby Confirms the Assignment.
Nov 20, 2017
From: NESTOR, JOHN J.
To: SPITFIRE PHARMA, INC.
Reel/Frame 044489/0655 →
Assignment of Assignor's Interest
Nov 21, 2017
From: NESTOR, JOHN J.
To: SPITFIRE PHARMA, INC.
Reel/Frame 044194/0772 →
Affidavit of Address Change
Feb 19, 2025
From: MEDERIS DIABETES, LLC
To: MEDERIS DIABETES LLC
Reel/Frame 070266/0875 →
Security Interest
May 14, 2025
From: ALTIMMUNE, INC.; SPITFIRE PHARMA, LLC
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 071108/0692 →